These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 12416262

  • 1. Simultaneous treatment with benzyl isothiocyanate, a strong bladder promoter, inhibits rat urinary bladder carcinogenesis by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okazaki K, Yamagishi M, Son HY, Imazawa T, Furukawa F, Nakamura H, Nishikawa A, Masegi T, Hirose M.
    Nutr Cancer; 2002; 42(2):211-6. PubMed ID: 12416262
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl isothiocyanate and N-butyl-N-(4-hydroxybutyl)nitrosamine in rats after initiation.
    Okazaki K, Umemura T, Imazawa T, Nishikawa A, Masegi T, Hirose M.
    Cancer Sci; 2003 Nov; 94(11):948-52. PubMed ID: 14611670
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Nakanishi K, Hagiwara A, Shibata M, Imaida K, Tatematsu M, Ito N.
    J Natl Cancer Inst; 1980 Nov; 65(5):1005-10. PubMed ID: 6933236
    [Abstract] [Full Text] [Related]

  • 5. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kitahori Y, Konishi N, Shimoyama T, Hiasa Y.
    Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279
    [Abstract] [Full Text] [Related]

  • 6. Chemopreventive effects of nimesulide, a selective cyclooxygenase-2 inhibitor, on the development of rat urinary bladder carcinomas initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Okajima E, Denda A, Ozono S, Takahama M, Akai H, Sasaki Y, Kitayama W, Wakabayashi K, Konishi Y.
    Cancer Res; 1998 Jul 15; 58(14):3028-31. PubMed ID: 9679967
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hiasa Y, Kitahori Y, Konishi N, Shimoyama T, Miyashiro A.
    J Natl Cancer Inst; 1985 Jan 15; 74(1):235-9. PubMed ID: 3855482
    [Abstract] [Full Text] [Related]

  • 9. Chemoprevention of mouse urinary bladder carcinogenesis by fermented brown rice and rice bran.
    Kuno T, Hirose Y, Yamada Y, Hata K, Qiang SH, Asano N, Oyama T, Zhi H, Iwasaki T, Kobayashi H, Mori H.
    Oncol Rep; 2006 Mar 15; 15(3):533-8. PubMed ID: 16465408
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Salim EI, Wanibuchi H, Morimura K, Kim S, Yano Y, Yamamoto S, Fukushima S.
    Carcinogenesis; 2000 Feb 15; 21(2):195-203. PubMed ID: 10657958
    [Abstract] [Full Text] [Related]

  • 11. Dietary beta-cryptoxanthin inhibits N-butyl-N-(4-hydroxybutyl)nitrosamine-induced urinary bladder carcinogenesis in male ICR mice.
    Miyazawa K, Miyamoto S, Suzuki R, Yasui Y, Ikeda R, Kohno H, Yano M, Tanaka T, Hata K, Suzuki K.
    Oncol Rep; 2007 Feb 15; 17(2):297-304. PubMed ID: 17203164
    [Abstract] [Full Text] [Related]

  • 12. Dose-dependent promotion by phenylethyl isothiocyanate, a known chemopreventer, of two-stage rat urinary bladder and liver carcinogenesis.
    Ogawa K, Hirose M, Sugiura S, Cui L, Imaida K, Ogiso T, Shirai T.
    Nutr Cancer; 2001 Feb 15; 40(2):134-9. PubMed ID: 11962248
    [Abstract] [Full Text] [Related]

  • 13. [Effect of UFT on urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine].
    Samma S, Tabata S, Nakatsuji F, Yoshie T, Moriya A, Matsuki H, Watanabe S, Babaya K, Hirao Y, Okajima E.
    Gan To Kagaku Ryoho; 1985 Aug 15; 12(8):1661-8. PubMed ID: 3927848
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats.
    Tatematsu M, Fukushima S, Aoki T, Mera Y, Inoue T, Ito N.
    Jpn J Cancer Res; 1987 Sep 15; 78(9):879-82. PubMed ID: 3117745
    [Abstract] [Full Text] [Related]

  • 17. Aging and urinary bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Fukushima S, Shibata M, Tamano S, Ito N, Suzuki E, Okada M.
    J Natl Cancer Inst; 1987 Aug 15; 79(2):263-7. PubMed ID: 3474459
    [Abstract] [Full Text] [Related]

  • 18. [Effect of FT-207 on bladder cancer in rats induced by BBN. II: The effect of oral administration of FT-207 during oncogenesis of bladder cancer].
    Okajima E, Hiramatsu T, Kihoin K, Ijuin M, Hirao Y, Ohara S, Babaya K, Tanaka M, Maruyama Y.
    Gan To Kagaku Ryoho; 1982 Mar 15; 9(3):473-9. PubMed ID: 6820898
    [Abstract] [Full Text] [Related]

  • 19. Lack of a modifying effect by the diuretic drug furosemide on the development of neoplastic lesions in rat two-stage urinary bladder carcinogenesis.
    Shibata MA, Hagiwara A, Tamano S, Ono S, Fukushima S.
    J Toxicol Environ Health; 1989 Mar 15; 26(3):255-65. PubMed ID: 2926828
    [Abstract] [Full Text] [Related]

  • 20. Chemopreventive effects of bovine lactoferrin on N-butyl-N-(4-hydroxybutyl)nitrosamine-induced rat bladder carcinogenesis.
    Masuda C, Wanibuchi H, Sekine K, Yano Y, Otani S, Kishimoto T, Tsuda H, Fukushima S.
    Jpn J Cancer Res; 2000 Jun 15; 91(6):582-8. PubMed ID: 10874209
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.